Acutus Medical to Announce Second Quarter 2020 Financial Results
04 September 2020 - 6:01AM
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced it
will release its financial results for the second quarter of 2020
after market close on Thursday, September 17, 2020. In conjunction
with the release, Acutus will host a conference call and webcast at
1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its
financial results and recent highlights.
Interested parties may access the live call via telephone by
dialing (833) 570-1131 for domestic callers or (914) 987-7078 for
international callers, using conference ID: 9767216. The live
webinar of the call may be accessed by visiting the Events section
of the Acutus website at ir.acutusmedical.com. A replay of the
webinar will be available shortly after the conclusion of the call
and will be archived on the company’s website for two weeks
following the earnings call.
About Acutus Medical, Inc. Acutus Medical is an
arrhythmia management company focused on improving the way cardiac
arrhythmias are diagnosed and treated. Acutus is committed to
advancing the field of electrophysiology with a unique array of
products and technologies which will enable more physicians to
treat more patients more efficiently and effectively. Through
internal product development, acquisitions and global partnerships,
Acutus has established a global sales presence delivering a broad
portfolio of highly differentiated electrophysiology products that
provide its customers with a complete solution for catheter-based
treatment of cardiac arrhythmias. Founded in 2011, Acutus is based
in Carlsbad, California.
Investor Contact:Caroline CornerWestwicke ICRD:
415-314-1725Caroline.corner@westwicke.com
Holly WindlerM: 619-929-1275media@acutusmedical.com
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Apr 2024 to May 2024
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From May 2023 to May 2024